No major threat seen, but pets can get flu, too
Athens Banner-Herald - Fri Nov 13, 12:22 am ETWhen word spread in 2005 that cats could catch avian flu, pet owners needlessly panicked.
115 Stories, most recent news story added Fri Nov 13, 1:15 pm ET
When word spread in 2005 that cats could catch avian flu, pet owners needlessly panicked.
Dear Editor: An animal biosafety laboratory for the purpose of studying bird flu and other highly infectious diseases will be built by the University of Wisconsin-Madison two blocks east of Camp Randall Stadium.
SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus.
PANAMA CITY — A draft document that would guide state hospitals in the event of a “pandemic influenza or other health emergency” has received input from officials with the Bay County Health Department. The draft was released earlier than...
Oct 20, 2009 (CIDRAP News) – The German Ministry of Food, Agriculture & Consumer Protection (BMELV) today announced that it has agreed to host the influenza gene sequence database of the Global Initiative on Sharing All Influenza Data (GISAID), putting its future on a more solid footing as the world enters the second wave of the H1N1 flu pandemic.
There is increasing evidence that, with best intent, current biological technology cannot supply the world's six billion humans, and animal populations, with vaccines against emerging diseases at a rate that can contend with a disease's rapid appearance and change, e.g., before the disease has come and gone.
An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.
Cell-based method cuts production time; increased demand boosts sales potential Vaccine shortages, commonplace a few years ago, soon may be a thing of the past now that more companies are producing and improving vaccines as governments worldwide prepare for potential pandemics.
Tourism Overview After buoyant, but somewhat weaker, growth in foreign visitor arrivals to Egypt in 2008, the tourism sector has experienced a significant downturn so far this year.
Medicago Inc. , a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles , today announced the appointment of Mr.
MONMOUTH JUNCTION, NJ--(Marketwire - 11/13/09) - MedaSorb Technologies Corporation (OTC.BB: MSBT - News ) and its wholly-owned subsidiary, CytoSorbents, Inc., provided an update of its clinical program. Dr. Phillip Chan, Chief Executive Officer, stated, "As we welcome many new investors to the company, I wanted to give a brief update on our European Sepsis Trial. As many know, MedaSorb has ...
World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments analyses the world vaccine market. This report gives the past, present scenario on the vaccines market and also forecast on future of vaccines market.
People who think they may have H1N1 flu need to stay away from work, avoid sneezing on their spouses and children and now, they have someone else to worry about infecting too -- their pets.
Best known for: Helping USAID address global health issues in developing countries. Among the concerns: malaria, avian influenza, tropical diseases, and maternal and child health programs.
Medicago Inc. , a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles , today announced that it received an invitation from the U.S.
LEIDEN, NETHERLANDS--(Marketwire - November 3, 2009) - Total revenues and other operating income increased by 15% to EUR 94.3 million. Operating profit of EUR 15.5 million versus EUR 9.6 million in Q3 2008. Quarter-end cash and short-term liquidities of EUR 411.9 million. Undiluted EPS of EUR 0.15 for the quarter. 2009 full year guidance reiterated: total revenues and other operating income ...